Publications
- The Impact of Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies with and without Apheresis on Platelet Aggregation in Familial Hypercholesterolemia2024 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Scientific Reports Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration2024 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- AtheroReview Současná role lipoproteinové aferézy v kontextu nových doporučení hypolipidemické farmakoterapie2024 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The Effect of 4-Methylcatechol on Platelets in Familial Hypercholesterolemic Patients Treated with Lipid Apheresis and/or Proprotein Convertase Subtilisin Kexin 9 Monoclonal Antibodies2023 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Rheoferéza v léčbě věkem podmíněné makulární degenerace2023 | Faculty of Medicine in Hradec Králové
- The world apheresis association registry, 2023 update2023 | Publication without faculty affiliation
- Hypolipidemic therapy in pregnant women with homozygous familial hypercholesterolemia2022 | Faculty of Medicine in Hradec Králové
- Pregnancy in homozygous familial hypercholesterolemia-A case series2022 | Faculty of Medicine in Hradec Králové
- Multiplex Protein Biomarker Profiling in Patients with Familial Hypercholesterolemia2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Science
Loading network view...
